1. Home
  2. USAS vs IOVA Comparison

USAS vs IOVA Comparison

Compare USAS & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USAS
  • IOVA
  • Stock Information
  • Founded
  • USAS 1998
  • IOVA 2007
  • Country
  • USAS Canada
  • IOVA United States
  • Employees
  • USAS N/A
  • IOVA N/A
  • Industry
  • USAS Metal Mining
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • USAS Basic Materials
  • IOVA Health Care
  • Exchange
  • USAS Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • USAS 1.1B
  • IOVA 975.1M
  • IPO Year
  • USAS N/A
  • IOVA N/A
  • Fundamental
  • Price
  • USAS $4.08
  • IOVA $1.99
  • Analyst Decision
  • USAS Strong Buy
  • IOVA Buy
  • Analyst Count
  • USAS 2
  • IOVA 11
  • Target Price
  • USAS $3.33
  • IOVA $10.80
  • AVG Volume (30 Days)
  • USAS 3.4M
  • IOVA 12.7M
  • Earning Date
  • USAS 11-11-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • USAS N/A
  • IOVA N/A
  • EPS Growth
  • USAS N/A
  • IOVA N/A
  • EPS
  • USAS N/A
  • IOVA N/A
  • Revenue
  • USAS $96,597,000.00
  • IOVA $241,525,000.00
  • Revenue This Year
  • USAS $25.34
  • IOVA $68.14
  • Revenue Next Year
  • USAS $84.70
  • IOVA $56.64
  • P/E Ratio
  • USAS N/A
  • IOVA N/A
  • Revenue Growth
  • USAS N/A
  • IOVA 636.99
  • 52 Week Low
  • USAS $0.80
  • IOVA $1.64
  • 52 Week High
  • USAS $5.12
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • USAS 53.93
  • IOVA 39.66
  • Support Level
  • USAS $3.71
  • IOVA $1.94
  • Resistance Level
  • USAS $4.25
  • IOVA $2.35
  • Average True Range (ATR)
  • USAS 0.29
  • IOVA 0.13
  • MACD
  • USAS -0.11
  • IOVA -0.02
  • Stochastic Oscillator
  • USAS 24.82
  • IOVA 6.32

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: